WaveDancer, Inc., a medical technology company based in Fairfax, VA, has recently entered into a merger agreement with Firefly Neuroscience, Inc. This all-stock transaction aims to combine the two companies and focus on the development and commercialization of Firefly's Artificial Intelligence driven Brain Network Analytics (BNA) platform, which has received clearance from the U.S. Food and Drug Administration. The merger is expected to be finalized in Q1-2024, and the combined company will operate under the name Firefly Neuroscience, Inc. and trade on the Nasdaq Global Market. Firefly Neuroscience, Inc., a privately held commercial-stage medical technology company, brings objective measurements of brain activity to the mental health and neurological disorder space. By providing accurate measurements, Firefly aims to enable effective management of these conditions, emphasizing the importance of measurement in the process. With their innovative approach, Firefly Neuroscience aims to make a significant impact in the field of mental health and neurological disorders.Generated from the website

Walcoff & Associates

Tiber Creek Consulting Inc

Volunteer Fairfax

ManTech International